Rheumatoid arthritis (RA) patients deal with a higher risk of bacterial and fungal infections
compared to the general population because of their dysregulated immune system as well …

This study aimed to evaluate the role of microRNAs (miRNA) as biomarkers of treatment
response in rheumatoid arthritis (RA) patients through a systematic review of the literature …

Introduction: Janus kinase inhibitors (JAK-i), a class of targeted synthetic disease-modifying
antirheumatic drugs (tDMARDs), are suggested as second or third-line therapies in …

Introduction Rheumatoid arthritis (RA) is an autoimmune disorder with a characteristic
chronic inflammation of the synovium that may lead to the destruction of the joints in …

Objective To compare the effectiveness of a strategy administering baricitinib versus one
using TNF-inhibitors (TNFi) in patients with rheumatoid arthritis (RA) after conventional …

Introduction Rheumatoid arthritis (RA) is a chronic autoimmune disease that significantly
impacts patients' quality of life. While treatment options have expanded over the years …

Ethnopharmacological relevance Phoenix dactylifera L.(date palm) seed is widely used in
Arabian traditional medicine to alleviate several health problems including inflammatory …

Objective To compare the efficacy and safety between baricitinib (BARI) and tofacitinib
(TOFA) for the treatment of the rheumatoid arthritis (RA) patients receiving methotrexate …

Rheumatoid arthritis (RA) is a complex autoimmune inflammatory rheumatic disease
characterized by an imbalance between immunological reactivity and immune tolerance …

Introduction The safety and efficacy of upadacitinib 15 mg (UPA15) through week 216 was
evaluated in patients with rheumatoid arthritis (RA) from the long-term extension (LTE) of the …